The application of CAR-T cell therapy in hematological malignancies: advantages and challenges

Chimeric antigen receptor T cell (CAR-T cell) therapy is a novel adoptive immunotherapy where T lymphocytes are engineered with synthetic receptors known as chimeric antigen receptors (CAR). The CAR-T cell is an effector T cell that recognizes and eliminates specific cancer cells, independent of maj...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Acta Pharm Sin B
Hlavní autoři: Zhao, Zijun, Chen, Yu, Francisco, Ngiambudulu M., Zhang, Yuanqing, Wu, Minhao
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2018
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6090008/
https://ncbi.nlm.nih.gov/pubmed/30109179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2018.03.001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky